Company intelligence / Profile preview

mxkAI BioSciences

Boulder, Colorado, United States

Ownership: Private
Development stage: Preclinical

Overview

Mosaic Biosciences provides comprehensive protein and antibody therapeutics research expertise to biotech, biopharma, and academic partners. They have taken multiple compounds from exploration to the clinic.

Modalities: Protein therapeuticsAntibody therapeutics
Industry: Drug Discovery Services

Drug pipeline

1 asset

DR-0201

Pre-clinical

Indications: B-cell depletion

Beyond the preview

Go deeper on mxkAI BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mxkAI BioSciences.

Explore the full profile